Anthony Ingenito, MD
Board Certifications: Radiation Oncology
Languages: English
Locations: Hackensack, NJ
Dr. Anthony Ingenito specializes in radiation oncology, and is board certified in radiation oncology. He has been treating patients in New Jersey for more than 15 years. Dr. Ingenito has been awarded the Abdol H. Islami, MD Award for Outstanding Transitional First Year Graduate Trainee of the Year; the Housestaff Clinical Research Award; Honored Member of America’s Registry of Outstanding Professionals; “Best Doctors” for Bergen County; and the Lifetime and VIP Member of Strathmore’s Who’s Who.
Education
Medical Education
University of Medicine and Dentistry of New Jersey, New Jersey Medical School, medical degree
Residency
Presbyterian Hospital in the City of New York, residency in radiation oncology
fellowship
St. Joseph’s Regional Medical Center, Paterson, fellowship in hematology-oncology
Professional Memberships
American Society for Therapeutic Radiology and Oncology
Awards and honors
Awards and honors
- Jersey’s Best Magazine Top Doctors: 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Jersey’s Best – Top Doctors for Women’s Health: 2012, 2013, 2014, 2016, 2017, 2022, 2023, 2024
- Jersey’s Best – Top Doctors for Children: 2016
- Jersey’s Best – Top Doctors for Cancer: 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2021, 2022, 2023, 2024
- New York Magazine: Top Doctors: 2014, 2016, 2017, 2019, 2020, 2021, 2022
- Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022
- Top Doctors: New York Metro Area (book series): 12th Edition, 13th Edition, 14th Edition, 15th Edition, 16th Edition, 17th Edition, 18th Edition
Hospital Affiliations
Hackensack University Medical Center
we are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.